AnalystsPaul JengPaul Jeng's Stock Forecasts
AnalystsPaul Jeng
Sectors:
Industries:
Analyst Ranking
Top 36%
#1856 out of 5290 analysts
Average Return
+12.23%
Win Rate
36%4 out of 11
Risk vs Reward
Poor
Good
Paul Jeng's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Context Therapeutics IncCNTX | +103.00% | $1.00 | $2.03 | 2025-09-18 - 2026-06-04 | Strong Buy |
Adagene IncADAG | +88.42% | $1.90 | $3.58 | 2025-11-24 - 2026-06-04 | Strong Buy |
Immatics NvIMTX | +54.01% | $6.61 | $10.18 | 2025-09-18 - 2026-06-04 | Strong Buy |
Ideaya Biosciences IncIDYA | +11.44% | $26.22 | $29.22 | 2025-09-18 - 2026-06-04 | Strong Buy |
Paul Jeng Analyst Color
Get additional color on Paul Jeng's coverage of popular stocks
Paul Jeng's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Strong Buy | $45.00 | +461.80% | Reiterates | 23 days ago |
Ideaya Biosciences IncIDYA | 3 | Strong Buy | $54.00 | +84.80% | Maintains | 2 months ago |
Adagene IncADAG | 2 | Strong Buy | $10.00 | +179.33% | Maintains | 2 months ago |
Context Therapeutics IncCNTX | 2 | Strong Buy | $5.00 | +146.31% | Reiterates | 2 months ago |
Immatics NvIMTX | 2 | Strong Buy | $19.00 | +86.64% | Maintains | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.